Sir, I wish to make the following observations about the article 'Fidelity of ECT devices: An alert to clinicians ' (Andrade, 2003) , published in the October-December 2003 issue of the Indian Journal of Psychiatry: 1. The authors of the paper, besides myself, are Kurinji S., Research Officer, Department of Psychopharmacology, and G. Laxmanna, Biomedical Engineer, Department of Biomedical Engineering, both at the National Institute of Mental Health and Neurosciences, Bangalore 560 029, India. 2. There are errors of commission and omission in the body of the paper as well as in the tables and references. It would perhaps be best that interested readers write to me for an error-free, electronic copy of the paper. Finally, as the reader will not be able to evaluate the devices from tables as printed, I wish to state that the compact device provided is acceptable and the best standards of accuracy. However, I stand by my comment that the fidelity of all ECT devices should be regulated as well as periodically confirmed. In several places, in both the abstract and text of their paper, Chavda et al (2004) reported that they randomized their patients; yet the paper described a single (aripiprazole, 15 mg/day) group. Was there another arm to the study, which was not reported in the paper?
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Reply
Sir, I thank Dr. Andrade for bringing to notice the mistake. In the clinical study, the design has been erroneously described as "randomised," which was a typographical error. This was an open-labelled single-group non-comparative study.
